- Report
- October 2024
- 196 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- September 2024
- 100 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- July 2024
- 150 Pages
Global
From €5679EUR$5,950USD£4,758GBP
- Report
- March 2025
- 363 Pages
Global
From €5201EUR$5,450USD£4,358GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- March 2025
- 175 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- January 2025
- 135 Pages
Global
From €2862EUR$2,999USD£2,398GBP
- Report
- May 2024
- 139 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- August 2024
- 150 Pages
Global
From €2662EUR$2,789USD£2,230GBP
- Report
- August 2024
- 150 Pages
Global
From €2662EUR$2,789USD£2,230GBP
- Report
- December 2020
- 120 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- March 2024
- 164 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- February 2024
- 245 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Report
- February 2023
- 120 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- February 2023
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- September 2022
- 239 Pages
Global
From €7158EUR$7,500USD£5,997GBP
- Report
- February 2024
- 204 Pages
Global
From €4533EUR$4,750USD£3,798GBP

Fluorouracil (5-FU) is a chemotherapy drug used in the treatment of cancer. It is a pyrimidine analog, which interferes with the synthesis of DNA and RNA, leading to cell death. It is used to treat a variety of cancers, including breast, colorectal, gastric, pancreatic, and head and neck cancers. It is also used in combination with other drugs to treat advanced or metastatic cancers. Fluorouracil is administered intravenously or topically, depending on the type of cancer being treated.
Fluorouracil is a widely used drug in the oncology market, and is often used in combination with other drugs to treat advanced or metastatic cancers. It is a generic drug, and is available in both branded and generic formulations. The branded formulations are typically more expensive than the generic versions.
Companies in the Fluorouracil market include Pfizer, Merck, Bristol-Myers Squibb, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more